Macrogenics Inc (MGNX)

Apr 03, 2025

MacroGenics (MGNX) Loses -48.74% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Apr 03, 2025

Mar 30, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Mar 30, 2025

Mar 28, 2025

Bank of New York Mellon Corp Has $540,000 Stock Holdings in MacroGenics, Inc. (NASDAQ:MGNX) - Defense World

Mar 28, 2025

Mar 28, 2025

HC Wainwright Increases Earnings Estimates for MacroGenics - Defense World

Mar 28, 2025

Mar 27, 2025

MacroGenics, Inc. (MGNX) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire

Mar 27, 2025

Mar 26, 2025

MacroGenics (NASDAQ:MGNX) Price Target Lowered to $2.00 at HC Wainwright - Defense World

Mar 26, 2025

Mar 25, 2025

MGNX stock touches 52-week low at $1.88 amid market challenges - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

MGNX stock touches 52-week low at $1.88 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

MacroGenics stock target cut to $2 at H.C. Wainwright By Investing.com - Investing.com Canada

Mar 25, 2025

Mar 24, 2025

Extensive-Stage Small Cell Lung Cancer (ESCLC) Clinical - openPR.com

Mar 24, 2025

Mar 24, 2025

Macrogenics Inc (NASDAQ: MGNX) Analysts Prediction On How Much It Could Rise - Stocks Register

Mar 24, 2025

Mar 24, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Receives $7.63 Consensus Price Target from Analysts - Defense World

Mar 24, 2025

Mar 23, 2025

MacroGenics, Inc. (NASDAQ:MGNX) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 23, 2025

Mar 23, 2025

MacroGenics’ SWOT analysis: pipeline progress, cash runway extend stock outlook - Investing.com Canada

Mar 23, 2025

Mar 23, 2025

StockNews.com Downgrades MacroGenics (NASDAQ:MGNX) to Hold - Defense World

Mar 23, 2025

Mar 22, 2025

MacroGenics’ SWOT analysis: pipeline progress, cash runway extend stock outlook By Investing.com - Investing.com South Africa

Mar 22, 2025

Mar 21, 2025

MacroGenics Inc’s 2024 Earnings Call Highlights - TipRanks

Mar 21, 2025

Mar 21, 2025

MacroGenics axes ADC drug following Phase II failure in prostate cancer - Yahoo

Mar 21, 2025

Mar 21, 2025

Macrogenics Inc (MGNX) Q4 2024: Everything You Need to Know Ahea - GuruFocus.com

Mar 21, 2025

Mar 21, 2025

Stifel maintains Hold on MacroGenics stock, price target at $6 By Investing.com - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Citizens JMP maintains MacroGenics stock with Market Outperform By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Citizens JMP maintains MacroGenics stock with Market Outperform - Investing.com India

Mar 21, 2025

Mar 21, 2025

MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Mar 21, 2025

Mar 21, 2025

MacroGenics Reports 2024 Financial Results and Progress - TipRanks

Mar 21, 2025

Mar 21, 2025

Macrogenics Inc (MGNX) Q4 2024 Earnings Call Highlights: Revenue Surge Amid Rising Expenses - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

MacroGenics (MGNX) Q4 2024 Earnings Call Transcript - Yahoo

Mar 20, 2025

Mar 20, 2025

MacroGenics (MGNX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance

Mar 20, 2025

Mar 20, 2025

MACROGENICS Earnings Results: $MGNX Reports Quarterly Earnings - Nasdaq

Mar 20, 2025

Mar 20, 2025

Earnings call transcript: MacroGenics beats Q4 2024 EPS expectations - Investing.com India

Mar 20, 2025

Mar 20, 2025

Earnings call transcript: MacroGenics beats Q4 2024 EPS expectations By Investing.com - Investing.com UK

Mar 20, 2025

Mar 20, 2025

MacroGenics Inc. (MGNX) reports earnings - Quartz

Mar 20, 2025

Mar 20, 2025

MacroGenics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 20, 2025

MacroGenics Inc Provides Update On Corporate Progress And 2024 Financial Results - Marketscreener.com

Mar 20, 2025

Mar 20, 2025

Macrogenics Inc (MGNX) Reports Q4 Revenue of $150 Million, Surpa - GuruFocus

Mar 20, 2025

Mar 20, 2025

MACROGENICS INC SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

MacroGenics Provides Update on Corporate Progress and 2024 Financial Results - GlobeNewswire

Mar 20, 2025

Mar 20, 2025

MacroGenics Triples Revenue to $150M as Cancer Drug Pipeline Advances - StockTitan

Mar 20, 2025

Mar 18, 2025

MGNX stock touches 52-week low at $2.15 amid sharp annual decline - Investing.com Australia

Mar 18, 2025

Mar 17, 2025

Macrogenics Stock Drops 77% After Study Deaths - The Wall Street Journal

Mar 17, 2025

Mar 17, 2025

Class Action Filed Against MacroGenics, Inc. (MGNX) Seeking Recovery for Investors – Contact Levi & Korsinsky - ACCESS Newswire

Mar 17, 2025

Mar 13, 2025

MacroGenics (MGNX) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025

Mar 13, 2025

MacroGenics at Barclays Conference: Strategic Insights on Pipeline and Partnerships By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

MGNX LAWSUIT ALERT: Levi & Korsinsky Notifies MacroGenics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ACCESS Newswire

Mar 12, 2025

Mar 12, 2025

MacroGenics at Barclays Conference: Strategic Insights on Pipeline and Partnerships - Investing.com

Mar 12, 2025

Mar 12, 2025

MGNX Deadline: MGNX Investors with Losses in Excess of $100K Hav - GuruFocus.com

Mar 12, 2025

Mar 11, 2025

MacroGenics at Leerink’s Conference: Strategic Pipeline Insights By Investing.com - Investing.com Canada

Mar 11, 2025

Mar 09, 2025

MacroGenics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before September 24, 2024 to Discuss Your RightsMGNX - ACCESS Newswire

Mar 09, 2025